{"id":13836,"date":"2020-09-11T14:35:13","date_gmt":"2020-09-11T18:35:13","guid":{"rendered":"https:\/\/www.cosprc.ca\/?p=13836"},"modified":"2021-06-20T09:28:12","modified_gmt":"2021-06-20T13:28:12","slug":"webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy","status":"publish","type":"post","link":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/","title":{"rendered":"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy"},"content":{"rendered":"\n

Date:<\/strong> Wednesday , Sep 23, 2020 <\/p>\n\n\n\n

Time:<\/strong> 7:00 PM – 8:00 PM EDT <\/p>\n\n\n\n

Target Audience:<\/strong>
The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with neovascular age-related macular degeneration and diabetic retinopathy.<\/p>\n\n\n\n

Overview:<\/strong>
Visual outcomes in patients with neovascular age-related macular degeneration (nAMD) and diabetic retinopathy (DR) have been greatly enhanced through the integration of anti\u2013vascular endothelial growth factor (VEGF) therapies into treatment protocols. In DR, early intervention with anti-VEGF therapies has demonstrated significant slowing of disease progression and a reduction in vision threatening complications. In those patients with nAMD, significant visual acuity gains have been demonstrated, yet treatment burden often leads to reduced patient adherence, resulting in suboptimal outcomes. Dosing strategies aimed at extending the time between dosing intervals while maintaining early visual acuity gains are evolving. In this educational activity, experts in the field will summarize newer anti-VEGF injection protocols that may improve the long-term management of DR and nAMD, as well as examine real-world clinical data that report on patient-related and anatomical factors that influence outcomes in patients being treated for nAMD and DR.<\/p>\n\n\n\n

Activity Chair:<\/strong>
W. Lloyd Clark, MD
Palmetto Retina Center, LLC
Assistant Clinical Professor of Ophthalmology
University of South Carolina School of Medicine
Columbia, SC<\/p>\n\n\n\n

Faculty:<\/strong>
Michael S. Ip, MD
Professor of Ophthalmology
Medical Director, Doheny Image Reading Center
Doheny Eye Institute
University of California \u2013 Los Angeles
Pasadena, CA<\/p>\n\n\n\n

Access Details: <\/strong>
Register here<\/a><\/p>\n\n\n\n

For more information on the webinar visit the website: http:\/\/www.vindicocme.com\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Date: Wednesday , Sep 23, 2020 Time: 7:00 PM – 8:00 PM EDT Target Audience:The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with neovascular age-related macular degeneration and diabetic retinopathy. Overview:Visual outcomes in patients with neovascular age-related macular degeneration (nAMD) and diabetic retinopathy (DR) […]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[305,315],"post_tag":[],"content_type":[325],"class_list":["post-13836","post","type-post","status-publish","format-standard","hentry","category-pour-les-ophtalmologistes","category-retine","content_type-reunions-et-conferences"],"acf":[],"yoast_head":"\nWebinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy - Practice Resource Centre<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy - Practice Resource Centre\" \/>\n<meta property=\"og:description\" content=\"Date: Wednesday , Sep 23, 2020 Time: 7:00 PM – 8:00 PM EDT Target Audience:The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with neovascular age-related macular degeneration and diabetic retinopathy. Overview:Visual outcomes in patients with neovascular age-related macular degeneration (nAMD) and diabetic retinopathy (DR) […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/\" \/>\n<meta property=\"og:site_name\" content=\"Practice Resource Centre\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-11T18:35:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-20T13:28:12+00:00\" \/>\n<meta name=\"author\" content=\"Fetun Delessa\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fetun Delessa\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\\\/\"},\"author\":{\"name\":\"Fetun Delessa\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#\\\/schema\\\/person\\\/3fca208dd4d156beb92f181ee1629eb1\"},\"headline\":\"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy\",\"datePublished\":\"2020-09-11T18:35:13+00:00\",\"dateModified\":\"2021-06-20T13:28:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\\\/\"},\"wordCount\":251,\"articleSection\":[\"Pour les ophtalmologistes\",\"R\u00e9tine\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\\\/\",\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\\\/\",\"name\":\"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy - Practice Resource Centre\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#website\"},\"datePublished\":\"2020-09-11T18:35:13+00:00\",\"dateModified\":\"2021-06-20T13:28:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#\\\/schema\\\/person\\\/3fca208dd4d156beb92f181ee1629eb1\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/\",\"name\":\"Practice Resource Centre\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cosprc.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#\\\/schema\\\/person\\\/3fca208dd4d156beb92f181ee1629eb1\",\"name\":\"Fetun Delessa\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g\",\"caption\":\"Fetun Delessa\"},\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/author\\\/rs9ebny670cpwyyn\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy - Practice Resource Centre","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/","og_locale":"fr_FR","og_type":"article","og_title":"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy - Practice Resource Centre","og_description":"Date: Wednesday , Sep 23, 2020 Time: 7:00 PM – 8:00 PM EDT Target Audience:The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with neovascular age-related macular degeneration and diabetic retinopathy. Overview:Visual outcomes in patients with neovascular age-related macular degeneration (nAMD) and diabetic retinopathy (DR) […]","og_url":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/","og_site_name":"Practice Resource Centre","article_published_time":"2020-09-11T18:35:13+00:00","article_modified_time":"2021-06-20T13:28:12+00:00","author":"Fetun Delessa","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Fetun Delessa","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/#article","isPartOf":{"@id":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/"},"author":{"name":"Fetun Delessa","@id":"https:\/\/www.cosprc.ca\/#\/schema\/person\/3fca208dd4d156beb92f181ee1629eb1"},"headline":"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy","datePublished":"2020-09-11T18:35:13+00:00","dateModified":"2021-06-20T13:28:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/"},"wordCount":251,"articleSection":["Pour les ophtalmologistes","R\u00e9tine"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/","url":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/","name":"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy - Practice Resource Centre","isPartOf":{"@id":"https:\/\/www.cosprc.ca\/#website"},"datePublished":"2020-09-11T18:35:13+00:00","dateModified":"2021-06-20T13:28:12+00:00","author":{"@id":"https:\/\/www.cosprc.ca\/#\/schema\/person\/3fca208dd4d156beb92f181ee1629eb1"},"breadcrumb":{"@id":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cosprc.ca\/fr\/webinar-innovative-treatment-trends-in-neovascular-age-related-macular-degeneration-and-diabetic-retinopathy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cosprc.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Webinar- Innovative Treatment Trends in Neovascular Age-Related Macular Degeneration and Diabetic Retinopathy"}]},{"@type":"WebSite","@id":"https:\/\/www.cosprc.ca\/#website","url":"https:\/\/www.cosprc.ca\/","name":"Practice Resource Centre","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cosprc.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.cosprc.ca\/#\/schema\/person\/3fca208dd4d156beb92f181ee1629eb1","name":"Fetun Delessa","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g","caption":"Fetun Delessa"},"url":"https:\/\/www.cosprc.ca\/fr\/author\/rs9ebny670cpwyyn\/"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-16 02:58:04","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts\/13836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/comments?post=13836"}],"version-history":[{"count":3,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts\/13836\/revisions"}],"predecessor-version":[{"id":19324,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts\/13836\/revisions\/19324"}],"wp:attachment":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/media?parent=13836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/categories?post=13836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/post_tag?post=13836"},{"taxonomy":"content_type","embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/content_type?post=13836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}